Close Menu

A*Star

The partners will collaborate in developing Atreca's single-cell sequencing technology to advance new cancer immunotherapies.

Members of the Genome 10K Consortium sequenced the genome of the ocean sunfish, Mola mola, comparing it to sequences from pufferfish and other related species.

The mass spectrometry instrument maker will provide A*Star's Bioprocessing Technology Institute with expertise and access to a Synapt G2-S instrument.

Singapore plans to spend $13.2 billion on research and development between 2016 and 2020.

The partners will focus on sequencing and analyzing bacteria and viruses that cause a number of diseases as well as those that make up human microbiomes.

The collaboration will further develop Agilent's AssayMAP Bravo platform to bridge gaps in analytical tests and standards for glycoprotein-based drugs. 

The partners will leverage IME's rare cell isolation technology, a microchip containing a microfabricated filter membrane to isolate and enrich fetal cells from maternal blood.

One collaboration aims to validate Curiox's technology on Luminex assays, while the other is to optimize it for RNA transfection with suspension cells. 

The software sifts through multiple omics datasets to better identify candidate mutations likely play a role in tumor development and survival.

The Singapore Agency for Science and Technology Research has launched a new Diagnostics Development Hub to help develop and commercialize diagnostic tests.

Pages

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.